USANA Health Sciences Balance Sheet Health
Financial Health criteria checks 5/6
USANA Health Sciences has a total shareholder equity of $497.2M and total debt of $786.0K, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are $632.8M and $135.6M respectively. USANA Health Sciences's EBIT is $93.1M making its interest coverage ratio -9.9. It has cash and short-term investments of $330.4M.
Key information
0.2%
Debt to equity ratio
US$786.00k
Debt
Interest coverage ratio | -9.9x |
Cash | US$330.42m |
Equity | US$497.20m |
Total liabilities | US$135.56m |
Total assets | US$632.76m |
Recent financial health updates
Recent updates
USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares
Apr 04USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Feb 08Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?
Jan 06USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation
Oct 23Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?
Sep 09Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital
Jul 27USANA Earnings Preview: From China's Challenge To India's Promise
Jul 21USANA Health Sciences says Brown will transition to CEO in July 2023
Feb 13Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture
Feb 02USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates
Oct 25Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return
Oct 18Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?
Jul 22Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled
Jul 07Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?
Jun 14Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?
May 31USANA: Soft Quarter, Bottomed Out Stock, 9.8x Ex-Cash P/E, 65% Upside
Apr 28Capital Investments At USANA Health Sciences (NYSE:USNA) Point To A Promising Future
Mar 05USANA: 15x P/E, 14% Net Cash, Stock Repurchases
Feb 17A Look At The Intrinsic Value Of USANA Health Sciences, Inc. (NYSE:USNA)
Jan 24At US$99.77, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List?
Jan 11Here's Why I Think USANA Health Sciences (NYSE:USNA) Might Deserve Your Attention Today
Nov 15USANA: Q3 Mixed Results, We See 35% Upside, 15% 10-Year EPS CAGR
Oct 28Financial Position Analysis
Short Term Liabilities: USNA's short term assets ($417.7M) exceed its short term liabilities ($118.8M).
Long Term Liabilities: USNA's short term assets ($417.7M) exceed its long term liabilities ($16.7M).
Debt to Equity History and Analysis
Debt Level: USNA has more cash than its total debt.
Reducing Debt: USNA's debt to equity ratio has increased from 0.05% to 0.2% over the past 5 years.
Debt Coverage: USNA's debt is well covered by operating cash flow (8987.4%).
Interest Coverage: USNA earns more interest than it pays, so coverage of interest payments is not a concern.